ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
4,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,2,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
6,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
6,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
6,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,7,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
8,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
